FRAT1 peptide decreases Aβ production in swAPP751 cells
Open Access
- 26 September 2003
- journal article
- Published by Wiley in FEBS Letters
- Vol. 553 (3) , 347-350
- https://doi.org/10.1016/s0014-5793(03)01042-1
Abstract
Recently, LiCl has been shown to inhibit amyloid β peptide secretion in association with diminished glycogen synthase kinase β (GSK3β) activity. However, it remains unclear if direct inhibition of GSK3β activity will result in decreased Aβ production. requently earranged in dvanced ‐cell lymphomas (FRAT1) protein is a negative regulator of GSK3α/β kinase activity. To examine whether direct inhibition of GSK3α/β kinase activity can lower Aβ production, a FRAT1 peptide was expressed in swAPP751 cells that produce high levels of Aβ. Our data demonstrate that cellular expression of FRAT1 peptide in swAPP751 cells increases both GSK3α and β phosphorylation on Ser21 and Ser9, respectively, while inhibiting kinase activity of both isoforms. Moreover, as a result of FRAT1 expression, the production of both total Aβ and Aβ1‐42 was significantly decreased. Thus, we provide evidence that direct regulation of GSK3α/β by FRAT1 peptide significantly decreases Aβ production in swAPP751 cells.Keywords
This publication has 24 references indexed in Scilit:
- Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathologyProceedings of the National Academy of Sciences, 2003
- Alzheimer's disease: treatments in discovery and developmentNature Neuroscience, 2002
- Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesisNature Medicine, 2002
- The presence of apoE4, not the absence of apoE3, contributes to AD pathologyJournal of Alzheimer's Disease, 2002
- Molecular biology of apolipoprotein ECurrent Opinion in Lipidology, 2002
- Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's DiseaseScience, 2002
- γ-Secretase: Substrates and InhibitorsMolecular Neurobiology, 2002
- GSK3 takes centre stage more than 20 years after its discoveryBiochemical Journal, 2001
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingPublished by Elsevier ,2001
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001